Pharmacoeconomic Analysis of Oral Antifungal Therapies Used to Treat Dermatophyte Onychomycosis of the Toenails

@article{Gupta1998PharmacoeconomicAO,
  title={Pharmacoeconomic Analysis of Oral Antifungal Therapies Used to Treat Dermatophyte Onychomycosis of the Toenails},
  author={Dr Aditya K. Gupta},
  journal={PharmacoEconomics},
  year={1998},
  volume={13},
  pages={243-256}
}
Until a few years ago, griseofulvin and ketoconazole were the only 2 oral agents available for the treatment of dermatophyte onychomycosis of the toenails. With the availability of the newer antifungal agents, such as itraconazole, terbinafine and fluconazole, the armamentarium of drugs available to treat onychomycosis has expanded. The objective of this study was to determine the relative cost effectiveness of the most commonly used oral antifungal agents in the US for the treatment of… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

Which Antifungal Agent for Onychomycosis?

PharmacoEconomics • 2012
View 13 Excerpts
Highly Influenced

Cost of Treatment for Onychomycosis

PharmacoEconomics • 2012
View 1 Excerpt

Evaluating costs for onychomycosis treatments: a practitioner's perspective.

Journal of the American Podiatric Medical Association • 2006

Pharmacoeconomics--an aid to better decision-making.

Journal of the European Academy of Dermatology and Venereology : JEADV • 2005

References

Publications referenced by this paper.
Showing 1-10 of 86 references

A placebo-controlled, randomized, double-blind trial of once weekly fluconazole (150, 300 or 140mg) in the treatment of distal subungual onychomycosis of the toenail

RK Scher
37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); • 1997

The prevalence of onychomycosis in Northeastern Ohio

M Charif, BE Elewski
Arch Dermatol • 1997

Similar Papers

Loading similar papers…